| Andrew Doherty, MD | |
|
2305 Genoa Business Park Dr Ste 220, Brighton, MI 48114-7005 | |
| (810) 494-6860 | |
| (810) 229-7012 |
| Full Name | Andrew Doherty |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 2305 Genoa Business Park Dr Ste 220, Brighton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104114040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 4301099510 (Michigan) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 4301099510 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
News Archive
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
An important receptor for estrogen in ovarian cells has been shown to suppress tumor growth, according to a new study published in the August 15 issue of the journal Cancer Research.
› Verified 1 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
An important receptor for estrogen in ovarian cells has been shown to suppress tumor growth, according to a new study published in the August 15 issue of the journal Cancer Research.
› Verified 1 days ago
| Entity Name | St Mary Mercy Hospital Professional |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528145554 PECOS PAC ID: 2365521226 Enrollment ID: O20080502000426 |
News Archive
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
An important receptor for estrogen in ovarian cells has been shown to suppress tumor growth, according to a new study published in the August 15 issue of the journal Cancer Research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Doherty, MD 24 Frank Lloyd Wright Dr, Po Box 0446 Lobby J, Ann Arbor, MI 48105-9484 Ph: (734) 747-6766 | Andrew Doherty, MD 2305 Genoa Business Park Dr Ste 220, Brighton, MI 48114-7005 Ph: (810) 494-6860 |
News Archive
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.
Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
An important receptor for estrogen in ovarian cells has been shown to suppress tumor growth, according to a new study published in the August 15 issue of the journal Cancer Research.
› Verified 1 days ago
Dr. Urva Naik, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8641 W Grand River Ave, Suite 4, Brighton, MI 48116 Phone: 810-229-6101 Fax: 810-229-0909 | |
Madeline Griffin Edwards, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8001 Challis Rd, Brighton, MI 48116 Phone: 810-227-9510 | |
Dr. Rosalyn Elizabeth Maben-feaster, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8001 Challis Drive, Brighton, MI 48116 Phone: 810-227-9510 | |
Dr. Francis Darling, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9062 Lake Dominion Dr, Brighton, MI 48114 Phone: 810-225-2143 | |
Dr. Christian Bogner, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7030 Whitmore Lake Rd, Brighton, MI 48116 Phone: 248-486-3636 | |
Laura April Gago, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2305 Genoa Business Park Dr, Suite 180, Brighton, MI 48114 Phone: 810-227-3232 |